| Scorecard |
|---|
|
3 / 5 Stars
|
|
Lipper
5
5
2
5
1
|
|
Zacks Investment Research
1
(Strong Buy)
|
|
Standard & Poor's
5 / 5 Stars
|
|
TheStreet.com
B-
(Buy)
|
Fund Holdings
Asset Allocation
| % Long | % Net | |
|---|---|---|
| Cash | 1.62 | 1.62 |
| Stocks | 3.32 | 3.32 |
| Bonds | 0.0 | 0.0 |
| Other | 1.36 | 1.36 |
| Foreign Bonds | 0.0 | 0.0 |
| Foreign Stocks | 93.69 | 93.69 |
| Convertible | 0.0 | 0.0 |
| Preferred | 0.0 | 0.0 |
Updated 04.30.2013
Top 10 Holdings
Performance as of 05.31.2013
Portfolio as of 04.30.2013
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| Laboratorios Almirall, S.A. | ALM | --- | 1.91 |
| MorphoSys AG | MOR | --- | 1.85 |
| Spirax-Sarco Engineering PLC | SPXSF | 9.66 | 1.7 |
| Wirecard AG | WDI | --- | 1.66 |
| Dunelm Group PLC | DNLM | --- | 1.62 |
| Swedish Orphan Biovitrum AB | SOBI | --- | 1.4 |
| Bunzl PLC | BNZL | --- | 1.29 |
| Bruker Corporation | BRKR | 9.79 | 1.28 |
| Bangkok Dusit Medical Services Public Company Limited | BDULF | 51.67 | 1.25 |
| Sirona Dental Systems, Inc. | SIRO | 11.85 | 1.22 |
